Octant Bio is a Biotech company based in Emeryville, California. It has raised $115M in total funding. Latest round: Series B.
Octant Bio is a Biotech company based in Emeryville, California. Octant Bio has raised $115M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in April 2022. The round record for Octant Bio runs through 2022; nothing later has been disclosed. Investors on record include Catalio Capital Management, Andreessen Horowitz Bio Fund, Allen & Co., 50 Years VC, Bristol Myers Squibb. 5 distinct backers are named across the disclosed rounds.
Totals shown for Octant Bio aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Emeryville and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026